维普期刊资源整合服务平台（V6.5）

71篇 您的检索式：作者名="Hamilton TC"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Characterization of immunotoxins active against ovarian cancer cell lines显示文摘	PIRKER R FITZGERALD DJP HAMILTON TC	1985	J Clin Invest1985，76，3：	1
2	Reversal of adriamycin resistance by verapamil in human ovarian cancer显示文摘	Hamilton TC Young RC	1984	Science1984，224，4652：	1
3	Platinum resistance: the role of DNA repair pathways显示文摘	Martin LP Hamilton TC Schilder RJ	2008	Clin Cancer Res2008，14，5：	1
4	Platinum resistance: the role of DNA repair pathways显示文摘	Martin LP Hamilton TC Schilder RJ	2008	Clin Cancer Res2008，14，5：	1
5	Mechanisms of drug resistance in ovarian cancer显示文摘	Ozols RF Hamilton TC	1993	Cancer1993，71，2：	1
6	Platinum resistance:the role of DNA repair pathways显示文摘	Martin LP Hamilton TC Schilder RJ	2008	Clin Cancer Res2008，14，5：	1
7	Use of a surrogate maker (human secreted alkaline phosphatase) to monitor in vivo tunor growth and anticancer drug efficacy in ovarian cancer xenografts显示文摘	Bao R Selvakumaran M Hamilton TC	2000	Gynecol Oncol2000，78，31：	1
8	Platinum resistance: the role of DNA repair pathways 显示文摘	Martin LP Hamilton TC Schilder RJ	2008	Clin Cancer Res2008，14，5：	1
9	Targeted gene therapy of ovarian caner using an ovarian-specific promoter显示文摘	Selvakumaran M Hamilton TC	2002	Gynecol Oncol2002，84，2：	1
10	Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF 显示文摘	Ferry KV Hamilton TC Johnson SW	2000	Biochem Pharmacol2000，60，9：	1
11	AKT2, a member of the protein kinase B family, is activated by growth factors, v - Ha - ras, and v - src through phosphatidylinositol 3 - Kinase in uuman ovarian epithelial cancer cells 显示文摘	Liu AX Testa JR Hamilton TC	1998	Cancer Research1998，58，7：	1
12	Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sufoximine mediated glutathione depletion 显示文摘	Winker MA Louie KG	1985	Biochem Pharmacol1985，34，：	1
13	Plalinum resistance:the role of DNA repair pathways显示文摘	Marlin I P Hamilton TC Schilder RJ	2008	Clin Cancer Res2008，14，5：	1
14	Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer 显示文摘	Hamilton TC LaCreta FP	1996	J Clin Oncol1996，14，1：	1
15	Stereoselective pharmacokinetics of L-buthionine-SR-sulfoximine in patients with cancer 显示文摘	Brennan JM Hamilton TC	1994	Drug Meta Disp1994，26，6：	1
16	Mechanisms of drug resistance in ovarian cancer 显示文摘	Johnson SW Ozols RE Hamilton TC	1993	Cancer1993，71，：	1
17	Platinum resistance:the role of DNA repair pathways显示文摘	Martin LP Hamilton TC Schilder RJ		0，，05：	1
18	Platinum resistance: the role of DNA repair pathways显示文摘	Martin LP Hamilton TC Schilder RJ	2008	Clin Cancer Bes2008，14，5：	1
19	Characterization of a xenograft model of human ovarian carcinoma with produces ascites and intraabdominal Carcinoma in mice显示文摘	Hamilton TC Young RC Louie KG	1984	Cancer Research1984，44，11：	1
20	Platinum resistance: the role of DNA repair pathways 显示文摘	Martin LP Hamilton TC Sehilder RJ	2008	Clin Cancer Res2008，14，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示